GB PHARMA ApS: Financial statements 2021
CVR: 36054220
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
GB PHARMA ApS (CVR 36054220) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -9,850 and a net result of DKK 2,571 compared with DKK -45,510 the year before. Equity in the 2021 report amounted to DKK -1,963,728.
- Revenue
- DKK 0
- Gross Profit
- DKK -9,850
- Profit/Loss
- DKK 2,571
- Equity
- DKK -1,963,728
- Total Assets
- DKK 50,852
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 0 | -10 t. | 3 t. | -2 mio. | - |
| 2020 | 0 | -13 t. | -46 t. | -2 mio. | 1 |
| 2019 | 47 t. | 19 t. | 25 t. | -1.9 mio. | 0 |
| 2018 | 43 t. | 23 t. | 41 t. | -1.9 mio. | 0 |
| 2017 | - | 9 t. | 50 t. | -2 mio. | 0 |
Official annual report
Find more companies like GB PHARMA ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
GB PHARMA ApS has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK -45,510.
About GB PHARMA ApS
GB PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2014. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Gunnar Kjems. The board consists of Gunnar Kjems (chair). The company is owned by Gunnar Kjems. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -10,000 and a net result of DKK 31,613 compared with DKK -4,949 the year before. Equity in the 2025 report amounted to DKK -1,902,842.